Respiratory Syncytial Virus vaccine in infants and toddlers.

Evaluate the efficacy, immunogenicity, and safety of a Respiratory Syncytial Virus vaccine in infancy and toddlers.

» Study Details | Apply for the Study

Symptoms of Schizophrenia

Do you have negative symptoms of schizophrenia? You could be eligible for a study of mobile apps

» Study Details | Apply for the Study

Bipolar Disorder with Depression Treatment

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY FOLLOWED BY OPEN-LABEL TREATMENT OF ALTO-100 IN ADULTS WITH BIPOLAR DISORDER CURRENTLY EXPERIENCING A MAJOR DEPRESSIVE EPISODE

» Study Details | Apply for the Study

Major Depressive Disorder

A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder

» Study Details | Apply for the Study

Major Depressive Disorder with Insomnia Symptoms

Double-Blind, Randomized Placebo-Controlled Study to Evaluate Efficacy and Safety and the Maintenance of Effect of 20-mg Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Patients with Major Depressive Disorder with Insomnia Symptoms

» Study Details | Apply for the Study

Participants with Type 2 Diabetes and Obesity

Investigational Tirzepatide Doses in Participants with Type 2 Diabetes and Obesity

» Study Details | Apply for the Study

Upcoming Studies for Men & Women

» Study Details | Apply for the Study

ADEPT-4 Alzheimer's Disease Psychosis Treatment

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXTfor the Treatment of Psychosis Associated with Alzheimer’s Disease (ADEPT –4 )

» Study Details | Apply for the Study

Prevention of Gluten-Specific T Cell Activation in Subjects with Celiac Dis

The ILLUMINATE-101 clinical research study is evaluating the safety and effectiveness of an investigational medication designed to reduce or eliminate the negative immune response to gluten in adults with celiac disease and participants are needed.

» Study Details | Apply for the Study

Subjects with Moderate to Severe Ulcerative Colitis

To be eligible for this study, a subject must be ≥ 18 years old, have a clinical diagnosis of active UC for ≥ 90 days

» Study Details | Apply for the Study

Combination Therapy in Women with Uterine Fibroids or Endometriosis who are

Study of the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women with Uterine Fibroids or Endometriosis who are at Risk for Pregnancy

» Study Details | Apply for the Study

Uterine Fibroids or Moderate to Severe Pain Associated with Endometriosis

Open-Label Study to Evaluate Bone Mineral Density with Long-Term Use of Relugolix Combination Tablet in Premenopausal Women with Heavy Menstrual Bleeding Associated with Uterine Fibroids or Moderate to Severe Pain Associated with Endometriosis

» Study Details | Apply for the Study

Non-Hormonal Pharmacotherapies Among Individuals Treated for Bothersome Vas

Non-Hormonal Pharmacotherapies Among Individuals Treated for Bothersome Vasomotor Symptoms

» Study Details | Apply for the Study

Evaluation of the Dexcom Continuous Glucose Monitoring (CGM) System in Preg

Evaluation of the Dexcom Continuous Glucose Monitoring (CGM) System in Pregnancy

» Study Details | Apply for the Study

Airsupra Asthma Study

A Randomized, Placebo-controlled, Double-blind, Multicenter, 12‑Week, 3-Way, Partial-replicate Crossover Pharmacodynamic Study to Assess the Equivalence of Budesonide and Albuterol (BDA) Delivered by MDI HFO Compared with BDA Delivered by MDI HFA in Participants with Asthma

» Study Details | Apply for the Study

Treatment of Acute Respiratory Syncytial Virus (RSV) Infection

A Phase 2 Randomized, Placebo-controlled Study of the Safety and Efficacy of Obeldesivir to Treat Nonhospitalized Adults With Acute Respiratory Syncytial Virus (RSV) Infection.

Experiencing a runny nose, cough, congestion, or wheezing? RSV might be the culprit, and a quick test can confirm. Take action, contact us today about a clinical trial, and help fight back against RSV.

No Cost RSV testing. See if you qualify for a clinical trial.

RSV can be a serious, life-threatening virus for high-risk adults who are 18 years or older and meet at least 1 of the following criteria: • Moderate or severe COPD • Asthma • Chronic lung disease • Chronic cardiovascular disease • ≥60 years of age (vaccinated or nonvaccinated).

Why join an RSV clinical trial? • Access to an investigational oral medication for RSV • Limited treatment options for high-risk adults • No FDA-approved oral treatment available • Don’t have to discontinue current medications to participate

» Study Details | Apply for the Study

RSV Ag Rapid Test Cassette in Detecting RSV Infection in any Age group

Study to Evaluate the Performance and Feasibility of AssureTech RSV Ag Rapid Test Cassette in Detecting RSV Infection in any Age group

» Study Details | Apply for the Study